Travere Therapeutics Ownership | Who Owns Travere Therapeutics?
Travere Therapeutics Ownership Summary
Travere Therapeutics is owned by 113.56% institutional investors, 0.65% insiders. Blackrock is the largest institutional shareholder, holding 9.86% of TVTX shares. Delaware Small Cap Core I is the top mutual fund, with 4.42% of its assets in Travere Therapeutics shares.
TVTX Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Travere Therapeutics | 113.56% | 0.65% | -14.21% |
Sector | Healthcare Stocks | 47.38% | 7.99% | 44.63% |
Industry | Biotech Stocks | 45.43% | 7.81% | 46.75% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Blackrock | 7.64M | 9.86% | $62.84M |
Armistice capital | 7.50M | 9.68% | $61.65M |
Deep track capital, lp | 7.37M | 9.51% | $60.58M |
Vanguard group | 6.62M | 8.54% | $54.41M |
Rock springs capital management lp | 4.48M | 5.78% | $36.84M |
Macquarie group | 4.37M | 5.64% | $35.90M |
State street | 3.51M | 4.53% | $28.86M |
Morgan stanley | 3.49M | 4.50% | $28.69M |
Millennium management | 2.95M | 3.81% | $24.24M |
Assenagon asset management | 2.21M | 2.86% | $18.20M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Finepoint capital lp | 1.78M | 4.15% | $14.60M |
Deep track capital, lp | 7.37M | 1.81% | $60.58M |
Kynam capital management, lp | 2.02M | 1.28% | $16.62M |
Rock springs capital management lp | 4.48M | 1.11% | $36.84M |
Parkman healthcare partners | 969.89K | 1.07% | $7.97M |
Birchview capital, lp | 122.00K | 0.93% | $1.00M |
Knott david m jr | 265.97K | 0.87% | $2.19M |
Armistice capital | 7.50M | 0.78% | $61.65M |
Highvista strategies | 219.42K | 0.66% | $1.80M |
Eversept partners, lp | 1.09M | 0.61% | $8.97M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Assenagon asset management | 2.21M | 0.04% | 2.00M |
Woodline partners lp | 1.28M | 0.10% | 1.28M |
Rock springs capital management lp | 4.48M | 1.11% | 1.06M |
Jacobs levy equity management | 1.89M | 0.06% | 765.16K |
Millennium management | 2.95M | 0.01% | 747.41K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
State street | 3.51M | 0.00% | -3.10M |
Deutsche bank ag\ | 946.60K | 0.00% | -1.45M |
Pictet asset management sa | 977.95K | 0.01% | -1.26M |
Renaissance | 2.20M | 0.03% | -658.20K |
Citigroup | 44.95K | 0.00% | -462.08K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Trexquant investment lp | 174.49K | 0.02% | 174.49K | $1.43M |
Norges bank | 71.00K | 0.00% | 71.00K | $583.62K |
Hudson bay capital management lp | 44.56K | 0.00% | 44.56K | $366.29K |
Mirae asset global etfs | 44.28K | 0.00% | 44.28K | $364.43K |
Engineers gate manager lp | 41.76K | 0.01% | 41.76K | $343.27K |
Sold Out
Holder | Change |
---|---|
Toronto dominion bank | -3.00 |
Nelson, van denburg & campbell wealth management group | -14.00 |
Global retirement partners | -19.00 |
Innealta capital | -28.00 |
Northwestern mutual wealth management | -39.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Jun 30, 2024 | 176 | -1.68% | 88,008,878 | 0.38% | 113 | 0.88% | 103 | 10.75% | 47 | -7.84% |
Mar 31, 2024 | 179 | 2.29% | 87,677,449 | 2.46% | 113 | 0.91% | 93 | 3.33% | 51 | -5.56% |
Dec 31, 2023 | 175 | -7.41% | 85,573,713 | 3.91% | 111 | 0.96% | 90 | -15.09% | 54 | 8.00% |
Sep 30, 2023 | 189 | 8.62% | 82,354,299 | -0.97% | 107 | 0.90% | 106 | -4.50% | 50 | 21.95% |
Jun 30, 2023 | 174 | -1.69% | 83,160,376 | -1.18% | 109 | 0.72% | 111 | -7.50% | 41 | 32.26% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Delaware Small Cap Core I | 3.45M | 4.42% | -21.39K |
Vanguard Total Stock Mkt Idx Inv | 2.51M | 3.21% | - |
Aviva Investors GlConvtAbsRet I USD Acc | 2.20M | 2.88% | -229.35K |
iShares Russell 2000 ETF | 1.90M | 2.43% | -4.27K |
HBM Healthcare Investments AG Ord | 1.50M | 1.96% | - |
Pictet Biopharmaceutical Mother | 1.09M | 1.43% | 5.28K |
Vanguard Institutional Extnd Mkt Idx Tr | 1.05M | 1.35% | -20.55K |
SPDR® S&P Biotech ETF | 1.01M | 1.30% | 11.19K |
Vanguard Strategic Equity Inv | 972.18K | 1.25% | 94.33K |
Vanguard Explorer Inv | 967.61K | 1.24% | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Oct 04, 2024 | LYONS GARY A | - | Sell | $285.23K |
Oct 04, 2024 | LYONS GARY A | - | Sell | $303.87K |
Sep 30, 2024 | Meckler Jeffrey A | - | Sell | $562.32K |
Sep 10, 2024 | Inrig Jula | CHIEF MEDICAL OFFICER | Sell | $8.88K |
Sep 09, 2024 | ROTE WILLIAM E. | SENIOR VICE PRESIDENT, R&D | Sell | $50.54K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q4 | - | 2 |
2024 Q3 | - | 9 |
2024 Q2 | - | 1 |
2024 Q1 | - | 18 |
2023 Q4 | - | 1 |
TVTX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools